select a format

Single User License
USD 2500 INR 160925
Site License
USD 5000 INR 321850
Corporate User License
USD 7500 INR 482775

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"


Brain Hemorrhage Global Clinical Trials Review, H1, 2015

Brain Hemorrhage Global Clinical Trials Review, H1, 2015


  • Products Id :- GDHC2615CTIDB
  • |
  • Pages: 94
  • |
  • March 2015
  • |
  • |
  Request for Sample Report

Executive Summary

Brain Hemorrhage Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Brain Hemorrhage Global Clinical Trials Review, H1, 2015" provides data on the Brain Hemorrhage clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Brain Hemorrhage. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Brain Hemorrhage. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons To Buy

Understand the dynamics of a particular indication in a condensed manner

Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

Obtain discontinued trial listing for trials across the globe

Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
www.kenresearch.com

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Brain Hemorrhage 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Brain Hemorrhage to Central Nervous System Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Brain Hemorrhage to Central Nervous System Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Unaccomplished Trials of Brain Hemorrhage 25

Subjects Recruited Over a Period of Time 27

Clinical Trials by Sponsor Type 28

Prominent Sponsors 29

Top Companies Participating in Brain Hemorrhage Therapeutics Clinical Trials 30

Prominent Drugs 32

Clinical Trial Profiles 33

Clinical Trial Overview of Top Companies 33

Novo A/S 33

Clinical Trial Overview of Novo A/S 33

Shenzhen Hornetcorn Bio-technology Company, Ltd. 34

Clinical Trial Overview of Shenzhen Hornetcorn Bio-technology Company, Ltd. 34

Pfizer Inc. 35

Clinical Trial Overview of Pfizer Inc. 35

Octapharma AG 36

Clinical Trial Overview of Octapharma AG 36

GlaxoSmithKline plc 37

Clinical Trial Overview of GlaxoSmithKline plc 37

BTG plc 38

Clinical Trial Overview of BTG plc 38

AstraZeneca PLC 39

Clinical Trial Overview of AstraZeneca PLC 39

Arbor Pharmaceuticals, LLC. 40

Clinical Trial Overview of Arbor Pharmaceuticals, LLC. 40

Clinical Trial Overview of Top Institutes / Government 41

The Johns Hopkins University 41

Clinical Trial Overview of The Johns Hopkins University 41

China Medical University Hospital 42

Clinical Trial Overview of China Medical University Hospital 42

Kawasaki Medical School Hospital 43

Clinical Trial Overview of Kawasaki Medical School Hospital 43

McMaster University 44

Clinical Trial Overview of McMaster University 44

Oriental Neurosurgery Evidence-Based-Study Team 45

Clinical Trial Overview of Oriental Neurosurgery Evidence-Based-Study Team 45

Seoul National University Hospital 46

Clinical Trial Overview of Seoul National University Hospital 46

Sunnybrook Health Sciences Centre 47

Clinical Trial Overview of Sunnybrook Health Sciences Centre 47

The George Institute for Global Health 48

Clinical Trial Overview of The George Institute for Global Health 48

Thomas Jefferson University 49

Clinical Trial Overview of Thomas Jefferson University 49

Five Key Clinical Profiles 50

Appendix 92

Abbreviations 92

Definitions 92

Research Methodology 93

Secondary Research 93

About GlobalData 94

Contact Us 94

Disclaimer 94

Source 94

List of Figures

Brain Hemorrhage Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Brain Hemorrhage Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Brain Hemorrhage Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Brain Hemorrhage Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10

Brain Hemorrhage Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Brain Hemorrhage Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Brain Hemorrhage Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13

Brain Hemorrhage Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14

Proportion of Brain Hemorrhage to Central Nervous System Clinical Trials, G7 Countries (%), 2015* 15

Brain Hemorrhage Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Brain Hemorrhage Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Brain Hemorrhage to Central Nervous System Clinical Trials, E7 Countries (%), 2015* 18

Brain Hemorrhage Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Brain Hemorrhage Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Brain Hemorrhage Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21

Brain Hemorrhage Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22

Brain Hemorrhage Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Brain Hemorrhage Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Brain Hemorrhage Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27

Brain Hemorrhage Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 28

Brain Hemorrhage Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29

Brain Hemorrhage Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30

Brain Hemorrhage Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32

GlobalData Methodology 93

List of Tables

Brain Hemorrhage Therapeutics, Global, Clinical Trials by Region, 2015* 7

Brain Hemorrhage Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Brain Hemorrhage Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Brain Hemorrhage Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10

Brain Hemorrhage Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Brain Hemorrhage Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Brain Hemorrhage Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13

Brain Hemorrhage Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14

Proportion of Brain Hemorrhage to Central Nervous System Clinical Trials, G7 Countries (%), 2015* 15

Brain Hemorrhage Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Brain Hemorrhage Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Brain Hemorrhage to Central Nervous System Clinical Trials, E7 Countries (%), 2015* 18

Brain Hemorrhage Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Brain Hemorrhage Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Brain Hemorrhage Therapeutics, Global, Clinical Trials by Phase, 2015* 21

Brain Hemorrhage Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22

Brain Hemorrhage Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Brain Hemorrhage Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Brain Hemorrhage Therapeutics, Global, Suspended Clinical Trials, 2015* 25

Brain Hemorrhage Therapeutics, Global, Withdrawn Clinical Trials, 2015* 25

Brain Hemorrhage Therapeutics, Global, Terminated Clinical Trials, 2015* 26

Brain Hemorrhage Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27

Brain Hemorrhage Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 28

Brain Hemorrhage Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29

Brain Hemorrhage Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31

Brain Hemorrhage Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32

Brain Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Novo A/S, 2015* 33

Brain Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Shenzhen Hornetcorn Bio-technology Company, Ltd., 2015* 34

Brain Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 35

Brain Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Octapharma AG, 2015* 36

Brain Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2015* 37

Brain Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by BTG plc, 2015* 38

Brain Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2015* 39

Brain Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Arbor Pharmaceuticals, LLC., 2015* 40

Brain Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by The Johns Hopkins University, 2015* 41

Brain Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by China Medical University Hospital, 2015* 42

Brain Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Kawasaki Medical School Hospital, 2015* 43

Brain Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by McMaster University, 2015* 44

Brain Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Oriental Neurosurgery Evidence-Based-Study Team, 2015* 45

Brain Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2015* 46

Brain Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Sunnybrook Health Sciences Centre, 2015* 47

Brain Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by The George Institute for Global Health, 2015* 48

Brain Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Thomas Jefferson University, 2015* 49

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Brain Hemorrhage Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Brain Hemorrhage, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.


Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com